NEWS

Nightstar Therapeutics – Novel Gene Therapy Company And Recent IPO – Seeking Alpha

Seeking AlphaNightstar Therapeutics – Novel Gene Therapy Company And Recent IPOSeeking AlphaLondon, UK and Lexington, Massachusetts based gene therapy company Nightstar Therapeutics (NITE) recently launched its IPO on NASDAQ offering 5.36 million ADS (… Continue reading

BrainStorm enrolls first patients in advanced ALS stem cell trial – Business Insider

KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialBusiness InsiderTEL AVIV, Oct 16 (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral… Continue reading

BrainStorm enrolls first patients in advanced ALS stem cell trial – Reuters

WeeklyHubBrainStorm enrolls first patients in advanced ALS stem cell trialReutersTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS)… Continue reading

BrainStorm enrolls first patients in advanced ALS stem cell trial – Reuters

KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialReutersTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) … Continue reading

BrainStorm enrolls first patients in advanced ALS stem cell trial – WHTC

KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialWHTCTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at … Continue reading

BrainStorm enrolls first patients in advanced ALS stem cell trial – Nasdaq

KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialNasdaqTEL AVIV, Oct 16 (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis… Continue reading

Gene therapy for blindness heading for approval – Cosmos (blog)

Cosmos (blog)

Gene therapy for blindness heading for approval Cosmos (blog) The US Food and Drug Administration looks set to approve a gene therapy for the treatment of a rare form of blindness, following clinical trials and the recommendation of a panel of independent advisors. The therapy, marketed as Luxturna by developers … Spark Therapeutics’s success is lifting all gene therapy stocks even though risks remainSTAT (blog) New gene therapy gives hope to people born with inherited eye disorderThe Conversation UK FDA advisory committee vote 16-0 for first even gene therapy for rare blindnessNews-Medical.net PBS NewsHour –Science Recorder all 8 news articles »